论文部分内容阅读
磺脲类 (Ｓｕｌｆｏｎｙｌｕｒｅａａｇｅｎｔｓ ,ＳＵ)降糖药物继发失效 (Ｓｅｃｏｎｄａｒｙｆａｉｌｕｒｅｏｆｓｕｌｆｏｎｙｌｕｒｅａ ,ＳＦＳ)已成为Ⅱ型糖尿病治疗中人们普遍关注的问题。ＳＦＳ的原因尚不十分清楚 ,治疗也持有不同意见。本文对 31例ＳＦＳ患者 β细胞?
Secondaryfailure of sulfonylurea (SFS) by sulfonylurea agents (SUs) has become a common concern in the treatment of type 2 diabetes. The reason for SFS is not yet clear, and treatment also holds divergent views. In this paper, 31 cases of SFS patients with β cells?